Download this whitepaper to learn more.
The use of spatial biology (both RNA and protein) has become a powerful tool for characterizing and phenotyping cells within the tumor microenvironment. Unfortunately, a key practical challenge of the technology is how to increase the reproducibility, sensitivity, and accuracy of results.
This white paper highlights the latest strategies and solutions for generating whole-tissue data for enhanced histological context and a truly unbiased, reproducible approach to spatial analysis in oncology clinical trials.
What you’ll learn:
- Review of spatial biology in oncology trials today
- How whole tissue imaging of the tumor microenvironment can provide insight into the immune environment of specific cancer types
- How a unique AI-driven image analysis and advanced spatial analytics can be applied to discover cell types, populations, and morphological spatial context
- And more
Offered Free by: NeoGenomics
See All Resources from: NeoGenomics
